Passive Reabsorption as a Directional Membrane Flux
A drug filtered into the tubular lumen is not necessarily destined for excretion. If the permeant drug species can cross the tubular epithelium passively, it can move from lumen back toward blood. The direction and magnitude of that movement depend on membrane permeability, the effective area available for exchange, and the concentration gradient across the membrane. In a renal PBPK model, these quantities can be represented segment by segment.
The flux must be defined with a clear direction and concentration reference. Here, positive flux means movement from tubular lumen to blood. Concentrations refer to the freely dissolved, permeant species on each side of the membrane. This treatment is deliberately limited to passive movement: it does not model pH-dependent speciation, tubular transit, or transporter-mediated reabsorption.
The definition of \(K_{LB}\) is important. At equilibrium, \(C_B=K_{LB}C_L\), so the luminal concentration that balances a given blood concentration is \(C_B/K_{LB}\). The difference in parentheses is therefore a concentration difference on the lumen-referenced scale. When \(K_{LB}=1\), equal concentrations on the two sides imply no net passive flux. A value other than one represents an equilibrium partition preference; it does not itself create a net flux when the system is at equilibrium.
The product \(PS\) has units of volume per time: permeability has units of length per time and area has units of length squared. Multiplying \(PS\) by a concentration difference gives amount per time. If concentrations are in mg/L and \(PS\) is in mL/min, convert mg/L to mg/mL before calculating a flux in mg/min.
Deriving and Applying the Segmental Flux Law
The passive-flux expression is a linear permeability model. For a membrane with a uniform effective permeability, the flux per area is proportional to the driving concentration difference. Multiplying that relation by area gives a rate proportional to \(PA\). Because the blood-side concentration must first be expressed as its lumen-equivalent concentration at equilibrium, the driving difference is \(C_L-C_B/K_{LB}\), rather than simply \(C_L-C_B\) when partitioning is present.
This derivation assumes passive, linear exchange over the range considered; a fixed effective permeability and area for the segment; and concentrations that can be treated as representative of that segment at the time of calculation. It also assumes that the chosen \(K_{LB}\) consistently relates the two concentrations at equilibrium. A computed flux is a local segmental rate under those conditions, not by itself a prediction of the full luminal concentration profile.
Worked Example: Calculating Flux From Permeability and Area
Consider a hypothetical segment with \(P=0.012\) cm/min, \(A=250\) cm\(^2\), \(K_{LB}=2\), \(C_L=4\) mg/L, and \(C_B=2\) mg/L. Calculate the net passive flux.
First calculate the permeability-surface area product: $$ PS=(0.012\ \text{cm/min})(250\ \text{cm}^2)=3.00\ \text{cm}^3/\text{min}=3.00\ \text{mL/min}. $$
The equilibrium-reference concentration on the lumen side is \(C_B/K_{LB}=2/2=1\) mg/L. Thus the lumen-referenced driving difference is \(4-1=3\) mg/L, or \(0.003\) mg/mL. Substitution gives $$ J_{L\to B}=(3.00\ \text{mL/min})(0.003\ \text{mg/mL})=0.00900\ \text{mg/min}. $$
The positive result means net movement is from lumen to blood: the segment reabsorbs 0.00900 mg/min under the stated conditions. At equilibrium, with this same blood concentration and partition ratio, the lumen concentration would be 1 mg/L; the specified 4 mg/L is above that value.
From Segmental Flux to Renal Clearance
For a compound with filtration and secretion as well as passive reabsorption, urinary appearance reflects the balance of these processes. Let \(R_{\mathrm{fil}}\) be the filtered amount rate, \(R_{\mathrm{sec}}\) the net amount rate added to the lumen by secretion, and \(R_{\mathrm{abs}}\) the net passive amount rate transferred from lumen to blood. With positive \(R_{\mathrm{abs}}\) defined as reabsorption, the urinary excretion rate is
If the segmental passive fluxes are expressed in the same amount-per-time units, then \(R_{\mathrm{abs}}=\sum_i J_{L\to B,i}\) for the modeled segments. A negative segmental flux contributes negatively to this sum: passive movement from blood to lumen increases net urinary delivery. This accounting does not imply that the segment concentrations are independent of one another. In a full nephron model, the local concentrations must be made consistent with the model’s luminal and blood states.
Renal clearance is the urinary excretion rate divided by the plasma concentration used to define clearance. For filtration of unbound drug, \(R_{\mathrm{fil}}=\mathrm{GFR}\,f_u C_p\), where \(C_p\) is plasma concentration and \(f_u\) is its unbound fraction. Therefore,
This balance assumes rates are evaluated on a consistent basis, such as a common steady-state interval, and that the clearance denominator is the corresponding plasma concentration. It shows directly that positive net reabsorption reduces renal clearance relative to the same filtration and secretion rates without reabsorption. It does not require renal clearance to equal filtration clearance: secretion can raise it, and net passive blood-to-lumen movement can also raise urinary excretion.
Worked Example: Combining Two Segmental Reabsorption Rates
In a hypothetical steady-state calculation, plasma concentration is 10 mg/L and \(f_u=0.10\), so the unbound plasma concentration is 1 mg/L. Let GFR be 120 mL/min and net secretion be 0.0800 mg/min. Suppose two segments have the following representative values: segment 1 has \(PS=2.00\) mL/min, \(C_L=3.00\) mg/L, \(C_B=1.00\) mg/L, and \(K_{LB}=1\); segment 2 has \(PS=1.50\) mL/min, \(C_L=2.00\) mg/L, \(C_B=1.00\) mg/L, and \(K_{LB}=2\). Calculate renal clearance.
For segment 1, the driving difference is \(3.00-1.00/1=2.00\) mg/L, or 0.00200 mg/mL. Hence $$ J_{L\to B,1}=(2.00\ \text{mL/min})(0.00200\ \text{mg/mL}) =0.00400\ \text{mg/min}. $$ For segment 2, the difference is \(2.00-1.00/2=1.50\) mg/L, or 0.00150 mg/mL, giving $$ J_{L\to B,2}=(1.50\ \text{mL/min})(0.00150\ \text{mg/mL}) =0.00225\ \text{mg/min}. $$
The modeled net passive reabsorption rate is \(R_{\mathrm{abs}}=0.00400+0.00225=0.00625\) mg/min. The filtered rate is $$ R_{\mathrm{fil}}=(120\ \text{mL/min})(0.10)(0.0100\ \text{mg/mL})=0.120\ \text{mg/min}. $$
Thus urinary excretion is \(0.120+0.0800-0.00625=0.19375\) mg/min. Since 10 mg/L is 0.0100 mg/mL, renal clearance is $$ CL_R=\frac{0.19375\ \text{mg/min}}{0.0100\ \text{mg/mL}} =19.375\ \text{mL/min}\approx19.4\ \text{mL/min}. $$ Without passive reabsorption, the same filtration and secretion rates would give \(0.200\) mg/min and \(20.0\) mL/min. The calculated reabsorption lowers clearance by 0.625 mL/min in this example.
The segment concentrations are specified representative model values, not values inferred by chaining the two segment calculations. Predicting how concentrations change along the nephron requires additional luminal mass-balance and flow information.
Area, Gradients, and the Direction of Net Flux
Permeability and surface area act through their product \(PS\). Holding the concentrations and partition ratio fixed, doubling either \(P\) or \(A\) doubles the magnitude of the net flux. Neither change reverses its direction: direction is set by the sign of \(C_L-C_B/K_{LB}\). This distinction is useful when interpreting a PBPK parameter change. A larger exchange area can strengthen reabsorption when the lumen is above its equilibrium-reference concentration, but it can also strengthen passive blood-to-lumen movement when the lumen is below that reference.
Worked Example: A Passive Flux Directed Into the Lumen
Suppose a hypothetical segment has \(PS=4.00\) mL/min, \(K_{LB}=2\), \(C_L=1.00\) mg/L, and \(C_B=3.00\) mg/L. The equilibrium-reference luminal concentration is \(3.00/2=1.50\) mg/L. The driving difference is \(1.00-1.50=-0.500\) mg/L, or \(-0.000500\) mg/mL. Therefore, $$ J_{L\to B}=(4.00\ \text{mL/min})(-0.000500\ \text{mg/mL}) =-0.00200\ \text{mg/min}. $$
The negative sign indicates net passive movement from blood to lumen, not active secretion. For a hypothetical subject with \(C_p=20\) mg/L, \(f_u=0.20\), GFR \(=100\) mL/min, and net secretion \(=0.0200\) mg/min, filtration is \(100(0.20)(0.0200)=0.400\) mg/min. Here \(R_{\mathrm{abs}}=-0.00200\) mg/min, so excretion is \(0.400+0.0200-(-0.00200)=0.422\) mg/min. Since \(C_p=0.0200\) mg/mL, \(CL_R=0.422/0.0200=21.1\) mL/min. The passive flux increases excretion by 0.00200 mg/min relative to the same balance without that segmental flux.
Model Checks, Alternatives, and Limitations
Several checks help identify an inconsistent passive-reabsorption calculation. First, verify the equilibrium definition: with \(K_{LB}=C_B/C_L\), zero flux must occur when \(C_L=C_B/K_{LB}\). Second, check the direction: a luminal concentration above this reference gives positive reabsorption, while a concentration below it gives negative flux. Third, check units before multiplying \(PS\) by a concentration difference. Finally, confirm that summed segmental rates are all expressed using the same sign convention and time basis.
A frequent mistake is to define \(K_{LB}=C_B/C_L\) at equilibrium but then use \(C_L-K_{LB}C_B\) as the driving difference. That expression does not vanish at the equilibrium specified by the definition. The correction is to use \(C_L-C_B/K_{LB}\), as in this tutorial. An equivalent convention could define the reciprocal ratio, but the definition and equation must change together.
The segmental permeability model is a useful alternative to assuming that all filtered drug is excreted or assigning a single fixed fraction of filtered drug to reabsorption. It makes the assumed area, permeability, and local driving force explicit. Compared with a more detailed finite-volume nephron model, however, this local rate calculation does not resolve how luminal concentration evolves with flow and transit. Nor does it represent transporter kinetics, pH-dependent ionization, or changes in effective area and permeability over time. Those mechanisms require additional state variables or equations rather than an unexamined adjustment to \(PS\).
The model is most informative when segment-specific permeability and area are supported or constrained by data, and the relevant concentrations are available or predicted by the larger PBPK model. If fitted parameters compensate for incorrect local concentrations, a plausible total clearance can conceal incorrect segmental fluxes. Sensitivity checks should therefore vary \(PS\) and the driving concentration separately, and inspect both flux direction and total urinary excretion.
Check Your Understanding
Answer each question, then compare with the brief solutions below.
- A segment has \(PS=2.00\) mL/min, \(C_L=5.00\) mg/L, \(C_B=2.00\) mg/L, and \(K_{LB}=2\). What is the signed flux, and which direction does it indicate?
- At equilibrium, \(K_{LB}=C_B/C_L=3\) and \(C_B=6\) mg/L. What is the equilibrium luminal concentration?
- If positive net reabsorption increases while filtration and secretion remain fixed, what happens to renal clearance?
- Why is it incorrect to add two segmental \(PS\) values and use one concentration difference when the segments have different local concentrations?
- A calculation gives a negative \(J_{L\to B}\). Does that imply transporter-mediated secretion?
Solutions. (1) The lumen-equivalent blood concentration is \(2/2=1\) mg/L; the difference is 4 mg/L, or 0.004 mg/mL. Thus \(J=(2.00)(0.004)=0.00800\) mg/min, directed lumen to blood. (2) \(C_L=C_B/K_{LB}=6/3=2.00\) mg/L. (3) Clearance decreases because \(CL_R=(R_{\mathrm{fil}}+R_{\mathrm{sec}}-R_{\mathrm{abs}})/C_p\). (4) Each segment’s flux depends on its own driving difference, so calculate each \(PS_i(C_{L,i}-C_{B,i}/K_{LB,i})\) and then sum signed rates. (5) No. A negative value indicates net passive movement from blood to lumen under the stated gradient; active transporter-mediated secretion is a distinct mechanism.